Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors during the central anxious system, conolidine modulates alternate molecular targets. A Science Advances review located that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. https://conolidine-alkaloid-for-c21851.aboutyoublog.com/46150802/conoldine-alternative-natural-pain-relief-no-further-a-mystery